NGEN logo
NGEN NASDAQ CA

NervGen Pharma Corp. - Common stock

Website · IPO Mar 2019
$4.26
▼ $-0.10 (-2.29%)
Vol 612K

Wall Street Consensus

8 analysts · Apr 2026
1
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating

Price Chart

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Sep 2025 $-0.06 $-0.06 +$0.00
Jun 2025 $-0.05 $-0.13 $-0.08
Mar 2025 $-0.09 $-0.06 +$0.03
Dec 2024 $-0.09 $-0.13 $-0.04

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-1… 2025-0… 2025-0… 2025-0…
Revenue
Net Income -$5.3M -$8.6M -$3.9M -$9.1M -$4.2M

Financial Health

Free Cash Flow
-$5.3M
Net Debt
-$11.3M
Cash
$11.4M
Total Debt
$33K
As of Sep 30, 2025

Peer Comparison

Ticker Mkt Cap P/E P/S ROE Margin Beta
NGEN
TLRY $1.0B 1.3 -92.8% -258.5% 2.07
SNDL $427.4M 0.6 -8.4% -9.7% 0.84